Little Green Pharma (ASX:LGP)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Little Green Pharma.
RELATED STOCKHEAD STORIES
Health Check: Little Green Pharma’s European success is more than pot luck
Health Check: FDA casualties mount as Trump’s ‘revolution’ takes place
Psilocybin can tackle brain injuries and binge eating, and these ASX companies are in the game
Health Check: CSL’s blood business saves the day amid declining flu jab rates
Closing Bell: Cannabis stocks bounce back; Ovanti soars 275pc after hiring Zip’s ex-CFO
ASX Small Caps Lunch Wrap: Market climbs while Star gets handed another huge fine
Health Check: ‘Cannabis corner’ in the green with record revenues and favourable deals
Weed Week: Cannabis can ‘kill melanoma’; and Germany legalises weed possession
ASX Small Caps Lunch Wrap: Markets higher yada yada… Germans legalise Pot!
ASX Health Stocks: Singular Health shoots 60pc through the roof after breakthrough deal in US
Weed Week: Cannabis stocks down almost 20pc in 2023, but here’s why they could rebound by Q2 2024
ASX Health Stocks: Imagion and Microba’s positive Phase 1 results; and LGP’s first mover advantage in France
Weed Week: Cannabis boom a ‘matter of when, not if’; and NSW to allow residents to grow pot
